Risk of Neurodegeneration in Patients with Morgellons Disease: A Focus on the Potential Risk of Developing Alzheimer’s

Authors

  • Jase Grimm University of the People

DOI:

https://doi.org/10.18034/mjmbr.v8i2.579

Keywords:

Morgellons disease, Alzheimer’s disease, Neurodegeneration, Protrusion

Abstract

Morgellons disease is a distressing dermatologic condition that typically presents with multiple, non-healing skin lesions with filamentous protrusions. Initial presentation of the condition can often include various neurological symptoms with dermatologic symptoms. Common neurological symptoms include neuropathy, cognitive impairment, and dementia. Recent studies reveal that spirochetes are a causative agent of Morgellons disease. Chronic spirochete infection is strongly associated with neurodegeneration seen in dementia and Alzheimer’s disease. This paper will provide a brief overview of Morgellons and Alzheimer’s disease and will explore the possible risk of developing Alzheimer’s in Morgellons patients.

Downloads

Download data is not yet available.

Author Biography

  • Jase Grimm, University of the People

    University of the People, 595 E Colorado Blvd Suite 623, Pasadena, CA 91101, USA

References

Allen, H. B. (2016). Alzheimer’s disease: assessing the role of spirochetes, biofilms, the immune system, and amyloid-β with regard to potential treatment and prevention. J. Alzheimer’s Dis., 53(4.), 1271–1276. DOI: https://doi.org/10.3233/JAD-160388

Armstrong, R. A. (2019). Risk factors for Alzheimer’s disease. Folia Neuropathol, 57(2), 87–105. DOI: https://doi.org/10.5114/fn.2019.85929

Aung-Din, D., Sahni, D. R., Jorizzo, J. L., and Feldman, S. R. (2018). Morgellons disease: insights into treatment. Dermatol. Online J., 24(11). DOI: https://doi.org/10.5070/D32411041998

Barnhart, M. M. and Chapman, M. R. (2006). Curli biogenesis and function. Annu. Rev. Microbiol., 60, 131–147. DOI: https://doi.org/10.1146/annurev.micro.60.080805.142106

Breijyeh, Z. and Karaman, R. (2020). Comprehensive review on Alzheimer’s disease: Causes and treatment. Molecules, 25(24), p. 5789. DOI: https://doi.org/10.3390/molecules25245789

Middelveen, M. J. and Stricker, R. B. (2016). Morgellons disease: a filamentous borrelial dermatitis. Int. J. Gen. Med., vol. 9, p. 349. DOI: https://doi.org/10.2147/IJGM.S116608

Middelveen, M. J., Fesler, M. C., and Stricker, R. B. (2018). History of Morgellons disease: from delusion to definition. Clin. Cosmet. Investig. Dermatol., 11, p. 71. DOI: https://doi.org/10.2147/CCID.S152343

Sochocka, M., Zwolinska, K. and Leszek, J. (2017). The infectious etiology of Alzheimer’s disease. Curr. Neuropharmacol., 15(7), 996–1009. DOI: https://doi.org/10.2174/1570159X15666170313122937

Weller, J. and Budson, A. (2018). Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Research, vol. 7. DOI: https://doi.org/10.12688/f1000research.14506.1

--0--

Published

2021-09-03

Issue

Vol. 8 No. 2 (2021): July - December Issue

Section

Peer-reviewed Article

License

The CC BY-NC 4.0 license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge & be non-commercial, they don’t have to license their derivative works on the same terms.
|| View License Deed ||
|| View Legal Code ||
 
Publishing paper with the "Malaysian Journal of Medical and Biological Research" means that the author or authors retain the copyright in the paper.
This journal is granted an exclusive noncommercial reuse license by the author(s), but the author(s) are able to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis, etc, so long as the use is not directed at a commercial advantage or toward private monetary gain.
The author(s) can reuse the figures and tables and other information contained in their paper published by Malaysian Journal of Medical and Biological Research in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at a private monetary gain or commercial advantage.

How to Cite

Grimm, J. (2021). Risk of Neurodegeneration in Patients with Morgellons Disease: A Focus on the Potential Risk of Developing Alzheimer’s. Malaysian Journal of Medical and Biological Research, 8(2), 47-52. https://doi.org/10.18034/mjmbr.v8i2.579
Crossref
Scopus
Google Scholar
Europe PMC